Systemic complications and hypothermia.
Cooling for neonatal hypoxic-ischemic encephalopathy is a novel and promising neuroprotective therapy that requires significant understanding of how cooling affects all organ systems and interventions used to treat systemic complications of cooling in an intensive care setting. As cooling is used more widely and has been newly introduced in neonatal units, continued surveillance of its use in clinical practice is mandatory. Units offering cooling should strongly consider joining a registry (e.g. the Vermont-Oxford Neonatal Encephalopathy Registry in the USA or the TOBY Register in the UK) that facilitates benchmarking of short-term adverse effects and long-term outcomes of cooling and that supports local quality improvement efforts.
Sarkar
Subrata
S
Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of Michigan Health System, C.S. Mott Children's Hospital, Ann Arbor, Michigan 48109-0254, USA. subratas@med.umich.edu
Barks
John D
JD
D001238:Asphyxia Neonatorum / Q000150:complications*; D019985:Benchmarking / Q000458:organization & administration*; D002658:Developmental Disabilities / Q000517:prevention & control; D006801:Humans; D007036:Hypothermia, Induced / Q000379:methods*; D002534:Hypoxia, Brain / Q000517:prevention & control; D020925:Hypoxia-Ischemia, Brain / Q000209:etiology / Q000628:therapy*; D007231:Infant, Newborn; D007234:Infant, Premature; D007363:Intensive Care Units, Neonatal / Q000458:organization & administration*; D011785:Quality Assurance, Health Care / Q000458:organization & administration; D058996:Quality Improvement / Q000458:organization & administration*; D012041:Regional Medical Programs / Q000458:organization & administration; D016896:Treatment Outcome; D014481:United States